Protocole Emerges From Stealth With $6M Seed Round Led by Rare Capital.
Protocole was founded at this inflection point by Delphine Le Grand and Cindy Yan, who worked together in the longevity space, saw firsthand that demand for peptides was outpacing the infrastructure required to deliver them safely, consistently, and with proper clinical guidance.
Rather than offering individual compounds in isolation, Protocole structures its offering around goal-oriented protocols designed to support areas such as recovery, performance, and longevity.
Protocole Emerges From Stealth With $6M Seed Round Led by Rare Capital.
Protocole was founded at this inflection point by Delphine Le Grand and Cindy Yan, who worked together in the longevity space, saw firsthand that demand for peptides was outpacing the infrastructure required to deliver them safely, consistently, and with proper clinical guidance.
Rather than offering individual compounds in isolation, Protocole structures its offering around goal-oriented protocols designed to support areas such as recovery, performance, and longevity.
